ABOS

NASDAQStock

Acumen Pharmaceuticals, Inc.

$3.25-0.05 (-1.52%)

52-Week Range

$0.90

$3.37

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.21

Volume

333.4K

Avg Volume

331.7K

Performance

+31.47%

+60.19%

+168.29%

YTD

+63.37%

+157.81%

-17.71%

-83.58%

Price Chart

ETF Exposure

ABOS is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.03%	105,261	$355K	$1.27B	0.60%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	9,827	$32K	$2.36B	0.25%
VXF	Vanguard Extended Market ETF	0.00%	324,367	$843K	$84.10B	0.05%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	9,637	$32K	$40.55B	0.17%
DFAS	Dimensional - US Small Cap ETF	0.00%	7,256	$24K	$12.65B	0.26%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	55	$193	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,964	$7K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	9	$33	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,118,322	$2.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	5,882	$21K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	507	$2K	$1.29B	0.17%

About ABOS ETF Exposure

Acumen Pharmaceuticals, Inc. (ABOS) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $3.25. Investors can gain exposure to ABOS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABOS, sorted by portfolio weight.